Medtronic Plc
MDT
Market Cap$113.19B
Close$
Earnings Call Q1 2025
August 20, 2024 - AI Summary
Medtronic reported strong Q1 results, exceeding expectations with 5.3% organic revenue growth and 8% adjusted EPS growth.
The company raised its full-year revenue and EPS guidance, now expecting organic revenue growth of 4.5% to 5% for fiscal year 2025.
Medtronic's highest-growth businesses, including cardiac ablation solutions and structural heart, showed accelerated growth in Q1 and are expected to contribute more to overall growth in the coming quarters.
Exclusive for Stockcircle Pro members
Sign up
$119.78
35.7% upside
Current Fair Value
35.7% upsideUndervalued by 35.7% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $113.19 Billion |
|---|---|
| Enterprise Value | $140.81 Billion |
| Dividend Yield | $2.8 (3.14978472694312%) |
| Earnings per Share | $2.77 |
| Beta | 0.85 |
| Outstanding Shares | 1,293,300,000 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | 29.07 |
|---|---|
| PEG | 91.24 |
| Price to Sales | 3.53 |
| Price to Book Ratio | 2.39 |
| Enterprise Value to Revenue | 4.32 |
| Enterprise Value to EBIT | 26.08 |
| Enterprise Value to Net Income | 35 |
| Total Debt to Enterprise | 0.21 |
| Debt to Equity | 0.6 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About Medtronic Plc
CEO: Geoffrey Martha